Clinical Trial Update: Effects of Botulinum Toxin Injections in Patients With Hereditary Spastic Paraplegia [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial assessing botulinum toxin injections in patients with hereditary spastic paraplegia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Spastic Paraplegia

Drugs mentioned

• Botulinum toxin injections (botulinum toxin)

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Hereditary Spastic Paraplegia | Phase 2, Phase 3 | Status: COMPLETED